Literature DB >> 24756626

Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.

Ilana Kopolovic1, Theodore E Warkentin2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756626      PMCID: PMC4150708          DOI: 10.1503/cmaj.131449

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

Review 1.  Agents for the treatment of heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin
Journal:  Hematol Oncol Clin North Am       Date:  2010-08       Impact factor: 3.722

2.  Delayed-onset heparin-induced thrombocytopenia and thrombosis.

Authors:  T E Warkentin; J G Kelton
Journal:  Ann Intern Med       Date:  2001-10-02       Impact factor: 25.391

3.  Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia.

Authors:  C Pouplard; J Amiral; J Y Borg; S Laporte-Simitsidis; B Delahousse; Y Gruel
Journal:  Am J Clin Pathol       Date:  1999-05       Impact factor: 2.493

Review 4.  Fondaparinux: does it cause HIT? Can it treat HIT?

Authors:  Theodore E Warkentin
Journal:  Expert Rev Hematol       Date:  2010-10       Impact factor: 2.929

Review 5.  HIT paradigms and paradoxes.

Authors:  T E Warkentin
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  A 14-year study of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

7.  Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.

Authors:  Marc-André Pearson; Chantal Nadeau; Normand Blais
Journal:  Clin Appl Thromb Hemost       Date:  2013-11-27       Impact factor: 2.389

8.  Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia.

Authors:  T Bakchoul; A Giptner; A Najaoui; G Bein; S Santoso; U J H Sachs
Journal:  J Thromb Haemost       Date:  2009-04-30       Impact factor: 5.824

9.  Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.

Authors:  T E Warkentin; J I Sheppard; J C Moore; C S Sigouin; J G Kelton
Journal:  J Thromb Haemost       Date:  2008-05-17       Impact factor: 5.824

Review 10.  Post-transfusion purpura: a survey of 12 Danish cases with special reference to immunoglobulin G subclasses of the platelet antibodies.

Authors:  E Taaning; A Svejgaard
Journal:  Transfus Med       Date:  1994-03       Impact factor: 2.019

View more
  5 in total

Review 1.  Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

Authors:  Valentine Minet; Jean-Michel Dogné; François Mullier
Journal:  Molecules       Date:  2017-04-11       Impact factor: 4.411

2.  Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.

Authors:  Preethi Ramachandran; Fady Farag; Rewais Morcus; Vladimir Gotlieb
Journal:  Am J Case Rep       Date:  2019-03-09

3.  Argatroban-refractory, Heparin-induced Thrombocytopenia after Coronary Intervention with Radial Artery Occlusion.

Authors:  Mohammed Al-Sadawi; Michael Haddadin; Violeta Capric; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2019-07-14

4.  Treatment of refractory delayed onset heparin-induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG).

Authors:  Kimberley Doucette; Christin B DeStefano; Natasha A Jain; Allan L Cruz; Vera Malkovska; Kelly Fitzpatrick
Journal:  Res Pract Thromb Haemost       Date:  2017-06-19

5.  Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.

Authors:  Mohamed Aon; Omar Al-Shammari
Journal:  Case Rep Hematol       Date:  2020-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.